QMS Medical Allied Services Quarterly Results for Trading Insights
QMSMEDI • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹4 Cr
QSept 2025
QMS Medical Allied Services Quarterly Results Key Highlights
- Revenue of ₹45 Cr in Sept 2025 (-2.2% vs Mar 2025, +18.4% vs Sept 2024)
- Net Profit of ₹4 Cr in Sept 2025 (+0.0% vs Mar 2025, +0.0% vs Sept 2024)
- EBITDA of ₹7 Cr in Sept 2025 (-12.5% vs Mar 2025)
- Operating Margin of 15.0% in Sept 2025 (+1.0pp vs Mar 2025)
- Earnings Per Share of ₹1.71 in Sept 2025 (-8.6% vs Mar 2025)
QMS Medical Allied Services Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 45 | 46 | 47 | 38 | 32 | -2.2% | 18.4% |
| Net Profit (₹ Cr) | 4 | 4 | 3 | 4 | 2 | - | - |
| EBITDA (₹ Cr) | 7 | 8 | 7 | 8 | 4 | - | - |
| EPS (₹) | 1.71 | 1.87 | 1.64 | 1.93 | 0.86 | - | - |
| Operating Margin (%) | 15.0% | 14.0% | 14.0% | 19.0% | 12.0% | - | - |
QMS Medical Allied Services Share Price Trend Around Quarterly Results
Visualize QMS Medical Allied Services's 1-year price movement across quarterly results — ideal for logging trades in QMS Medical Allied Services share price
chart using Tickjournal. All values in ₹.
Related Pages for QMS Medical Allied Services
Additional stock information and data for QMSMEDI
Revenue Trend (₹ Cr)
Sept 2024
38
Jun 2025
47
Mar 2025
46
Sept 2025
45
Net Profit Trend (₹ Cr)
Sept 2024
4
Jun 2025
3
Mar 2025
4
Sept 2025
4
Operating Margin Trend (%)
Sept 2024
19.0%
Jun 2025
14.0%
Mar 2025
14.0%
Sept 2025
15.0%
Sector Competitors - Quarterly Performance Comparison
Comparing QMS Medical Allied Services quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores